Multiple Myeloma: International Myeloma Foundation : ASH 2011: Dr. Ladetto - Long-Term Results of the GIMEMA VTD Consolidation Trial In Autografted Multiple Myeloma Patients (VEL-03-096): Impact of Minimal Residual Disease Detection by Real Time Quantitative PCR On Late Recurrences and Overall Survival.

back

ASH 2011: Dr. Ladetto - Long-Term Results of the GIMEMA VTD Consolidation Trial In Autografted Multiple Myeloma Patients (VEL-03-096): Impact of Minimal Residual Disease Detection by Real Time Quantitative PCR On Late Recurrences and Overall Survival.

Marco Ladetto, MD
University of Torino
A.O.U. San Giovanni Battista
Torino, Italy

	12.06.11
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles

Be the first to comment